Medicare Enrolled

Dr. Fehmida Zahabi, MD

Rheumatology · Plano, TX
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
6300 STONEWOOD DR, Plano, TX 75024
4694672478
In practice since 2006 (19 years)
NPI: 1740397603 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Zahabi from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Zahabi? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Zahabi

Dr. Fehmida Zahabi is a rheumatology in Plano, TX, with 19 years in practice. Based on federal Medicare data, Dr. Zahabi performed 12,992 Medicare services across 496 unique beneficiaries.

Between the years covered by Open Payments, Dr. Zahabi received a total of $39,124 from 50 pharmaceutical and/or device companies across 1550 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Zahabi is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice▲ Top 36% volume in TX$ $39,124 industry payments

Medicare Practice Summary

Medicare Utilization ↗
12,992
Medicare services
Top 36% in TX for rheumatology
496
Unique beneficiaries
$15
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~684 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Golimumab infusion (Simponi Aria)11,850$10$90
Office visit, established patient (30-39 min)351$89$336
Blood draw (venipuncture)339$8$12
Office visit, established patient (20-29 min)211$65$225
Administration of chemotherapy into vein, 1 hour or less156$98$561
New patient office visit, complex (60-74 min)56$164$651
Bone density scan (DEXA)17$36$324
Office visit, established patient (10-19 min)12$43$135
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
91.2% high complexity
1.2% medium
7.6% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$39,124
Total received (2018-2024)
Avg $5,589/year across 7 years
Top 12% in TX for rheumatology
50
Companies
1,550
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$26,009 (66.5%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$10,695 (27.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$2,420 (6.2%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$3,489
2023
$2,927
2022
$4,932
2021
$9,214
2020
$5,753
2019
$7,428
2018
$5,381

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Janssen Biotech, Inc.
$5,497
UCB, Inc.
$4,456
PFIZER INC.
$4,334
Amgen Inc.
$3,771
NOVARTIS PHARMACEUTICALS CORPORATION
$2,663
GlaxoSmithKline, LLC.
$2,072
AbbVie Inc.
$2,071
ABBVIE INC.
$1,669
Novartis Pharmaceuticals Corporation
$1,551
AbbVie, Inc.
$1,463
Lilly USA, LLC
$1,360
E.R. Squibb & Sons, L.L.C.
$1,252
Genentech USA, Inc.
$834
AstraZeneca Pharmaceuticals LP
$775
GENZYME CORPORATION
$742
Aurinia Pharma U.S., Inc.
$608
Radius Health, Inc.
$548
Horizon Therapeutics plc
$309
Flexion Therapeutics, Inc.
$295
Mallinckrodt Hospital Products Inc.
$293
Celgene Corporation
$267
Mallinckrodt Enterprises LLC
$253
Janssen Scientific Affairs, LLC
$240
Boehringer Ingelheim Pharmaceuticals, Inc.
$235
Mallinckrodt LLC
$232
ANI Pharmaceuticals, Inc.
$180
Fresenius Kabi USA, LLC
$155
Alexion Pharmaceuticals, Inc.
$154
Merck Sharp & Dohme Corporation
$133
Horizon Pharma plc
$73
Cumberland Pharmaceuticals, Inc.
$73
Sandoz Inc.
$70
MEDAC PHARMA, INC.
$62
Organon LLC
$55
Gilead Sciences, Inc.
$52
SCILEX PHARMACEUTICALS INC.
$49
Octapharma USA, Inc.
$31
Antares Pharma, Inc.
$30
Sobi, Inc
$26
Takeda Pharmaceuticals U.S.A., Inc.
$24
Alvogen Inc
$21
Bioventus LLC
$21
Medtronic USA, Inc.
$18
IBSA Pharma Inc.
$16
Kowa Pharmaceuticals America, Inc.
$16
Novo Nordisk Inc
$16
Eisai Inc.
$15
Celltrion USA Inc.
$15
Abbott Laboratories
$15
Mission Pharmacal Company
$11
Top 3 companies account for 36.5% of total payments
Associated products mentioned in payments ›
ACTHAR · AMJEVITA · AVSOLA · Actemra · BENLYSTA · Bimzelx · COSENTYX · CYLTEZO · Cimzia · Dayvigo · Durolane · EVENITY · EVUSHELD · Enbrel · FORTEO · HUMIRA · HYRIMOZ · Humira · IDACIO · INFLECTRA · KEVZARA · KRYSTEXXA · Kineret · LUPKYNIS · LYRICA · Neuromodulation Dspsbls and Accs · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OFEV · ORENCIA · Otezla · Otrexup · PENNSAID · PURIFIED CORTROPHIN GEL · Prolia · RAYOS · REDITREX · REMICADE · RENFLEXIS · RINVOQ · Rasuvo · Rinvoq · Rituxan · SAPHNELO · SIMPONI · SIMPONI ARIA · SKYRIZI · STELARA · STRENSIQ · Saxenda · Seglentis · TALTZ · TAVNEOS · TERIPARATIDE · TREMFYA · Tavneos · Tirosint · Tyenne · Tymlos · UBRELVY · Uloric · Uribel · VECTRIS · VELSIPITY · VIMOVO · XELJANZ · YUFLYMA · ZTLido · Zilretta
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (66%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $301 per 100 Medicare services performed
Looking for a rheumatology in Plano?
Compare rheumatologys in the Plano area by procedure volume, costs, and industry payment transparency.
Browse rheumatologys nearby

Geographic Context

Rheumatologys within 10 mi
94
Per 100K population
8.4
County median income
$117,588
Nearest hospital
CHILDRENS MEDICAL CENTER PLANO
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Zahabi is a mixed practice specialist, with moderate Medicare volume, and high industry engagement (low-engagement, top 12%), with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Zahabi experienced with golimumab infusion (simponi aria)?
Based on Medicare claims data, Dr. Zahabi performed 11,850 golimumab infusion (simponi aria) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Zahabi receive payments from pharmaceutical companies?
Yes. Dr. Zahabi received a total of $39,124 from 50 companies across 1,550 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Zahabi's costs compare to other rheumatologys in Plano?
Dr. Zahabi's average Medicare payment per service is $15. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Zahabi) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →